The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.00
Bid: 118.00
Ask: 122.00
Change: 7.50 (6.67%)
Spread: 4.00 (3.39%)
Open: 117.50
High: 120.50
Low: 117.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Joint poultry vaccine development licencing deal

19 Nov 2018 07:00

ECO Animal Health Group plc

(AIM: EAH)

ECO Animal Health and University of Georgia sign poultry vaccine development licencing deal

ECO Animal Health Ltd (ECO), a wholly owned subsidiary of ECO Animal Health Group plc, is pleased to announce that it has entered into a licensing deal with the Poultry Diagnostic & Research Center, College of Veterinary Medicine at the University of Georgia (UGA).

This deal, at a cost of just over $1 million in phased payments of eight quarterly instalments over a two year period, allows ECO to license research related innovations leading to the development of potential vaccines in the field of Mycoplasma gallisepticum, a bacterium that can cause severe respiratory disease in poultry. A joint steering committee will meet monthly to review data, monitor progress and reach go/no-go decisions.

Peter Lawrence, Chairman of ECO Animal Health Group plc said, “Mycoplasma-related illnesses in poultry can be financially devastating to commercial poultry producers with global losses estimated at more than £500 million annually. We are delighted to have entered into this collaboration with UGA and expect that further innovative developments will follow”.

Professor Naola Ferguson-Noel, a researcher in the Poultry Diagnostic & Research Center said, “Although Mycoplasma control programs are often based on biosecurity, early detection, quarantine and elimination of positive flocks, vaccination can be a very effective option in some circumstances. I do think a vaccine is within reach.”

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

Peter Lawrence 020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900

-----------------------------------------------------

About ECO Animal Health Ltd

ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.

About University of Georgia

UGA is an American public, flagship, and comprehensive research university based in Athens, Georgia. It has been ranked in the Top 10 of all USA universities for licensing deals for the past decade and, to date, more than 700 UGA products and technologies have been introduced to the marketplace.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181118005025/en/

Copyright Business Wire 2018

Date   Source Headline
31st Aug 20227:00 amRNSFinal Results for the Year Ended 31 March 2022
26th Aug 20221:13 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHolding(s) in Company
22nd Aug 20227:00 amRNSRevised Notice of Results
9th Aug 20227:00 amRNSDirectorate Change
8th Aug 202211:05 amRNSSecond Price Monitoring Extn
8th Aug 202211:00 amRNSPrice Monitoring Extension
8th Aug 20227:00 amRNSNotice of Results and Trading Update
11th Jul 20227:00 amRNSNew Banking Facility
6th Jul 20227:00 amRNSPartnership with Moredun Research Institute
15th Jun 20227:35 amRNSPartnership with Imperial College
12th May 202212:05 pmRNSDirector/PDMR Dealings
29th Apr 202211:47 amRNSBlock Listing Interim Review
1st Apr 20227:00 amRNSDirector/PDMR Dealings
30th Mar 20227:00 amRNSDirector/PDMR Dealings
23rd Mar 20225:53 pmRNSDirector/PDMR Dealing
21st Mar 20227:00 amRNSDirector/PDMR Dealing
15th Mar 20227:00 amRNSPre-close Trading Update
23rd Feb 20227:00 amRNSNew Marketing Authorisations for Aivlosin in China
1st Feb 20221:53 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSInvestor Presentation
18th Jan 20227:01 amRNSHolding(s) in Company
18th Jan 20227:00 amRNSChief Executive Officer Appointment
13th Jan 20229:29 amRNSHolding(s) in Company
12th Jan 20227:00 amRNSTrading update, Appointment of Joint Broker & CMD
6th Dec 20218:14 amRNSHolding(s) in Company
1st Dec 20217:00 amRNSBoard Appointment
30th Nov 202112:39 pmRNSDirector Dealings
25th Nov 20217:00 amRNSResults for the six months ended 30 September 2021
23rd Nov 20217:00 amRNSInvestor Presentation covering Interim Results
1st Oct 20218:47 amRNSTotal Voting Rights & Share Capital
27th Sep 202112:06 pmRNSDeferred Share Awards to Executive Directors
17th Sep 20217:00 amRNSResult of AGM
16th Sep 20217:00 amRNSAGM Statement
19th Aug 20217:00 amRNSPublication of Annual Report and Notice of AGM
12th Aug 20218:30 amRNSHolding(s) in Company
28th Jul 20212:40 pmRNSDirectors Dealings
26th Jul 20217:00 amRNSBoard Changes
26th Jul 20217:00 amRNSFinal Results for Year Ended 31 March 2021
28th May 20212:31 pmRNSTotal Voting Rights
12th May 20211:55 pmRNSHolding(s) in Company
30th Apr 20212:00 pmRNSBlock listing Interim Review
30th Apr 20212:00 pmRNSTotal Voting Rights
29th Apr 20217:00 amRNSDirector/PDMR Shareholding
21st Apr 20214:33 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSTrading Update
4th Mar 20213:07 pmRNSResult of AGM & GM
25th Feb 202111:15 amRNSClarification of new long term incentive plan
18th Feb 20211:59 pmRNSHolding(s) in Company
4th Feb 20217:30 amRNSRestoration - Eco Animal Health Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.